510(k) · Decided
Recalled · 2003Smart Control Nitinol Stent Transhepatic Biliary System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Cordis Corp. · FGE Stents, Drains And Dilators For The Biliary Ducts
Cleared on Aug 14, 2002 as substantially equivalent to K012993 (Cordis Corp., 2001) and 3 other predicates after a 65-day review. Its family tree reaches back 2 generations to 2001. 24 later devices descend from it. It has been recalled once.
- Decided
- Aug 14, 2002
- Review
- 65 days
- Class
- Class II
- Product code
- FGE
- Recalls
- 1
- Predicates
- 4
Its longest line of descent runs back 2 generations to K010445 (2001). 5 ancestors in all, the oldest K971010 (1997). 24 later devices descend from it, 8 citing it directly.
- Root · 2 generations backK010445 Precise Nitinol Stent Transhepatic Billary SystemCordis Corp. · 2001
- 1 generation backK012993 Modification to Precise Nitinol Stent Transhepatic Biliary SystemCordis Corp. · 2001 · Recalled
- This deviceK021898 Smart Control Nitinol Stent Transhepatic Biliary SystemCordis Corp. · 2002
- Descendant · cites it directly · 10 of its ownK031777 Modeification to: Smart Control Nitinol Stent Transhepatic Biliary…Cordis Corp. · 2003 · Recalled
- Descendant · cites it directly · 9 of its ownK032457 Modification to Smart Control Nitinol Stent Transhepatic Biliary…Cordis Corp. · 2003
- Descendant · 2 generations on · 6 of its ownK060557 Suresave TM Self-Expandable Nitinol Stent and Precision TM Delivery…Idev Technologies, Inc. · 2006
- Descendant · 3 generations on · 5 of its ownK071646 Supera Interwoven Self-Expanding Biliary Nitinol Stent Delivery…Idev Technologies, Inc. · 2008
- Descendant · 3 generations on · 4 of its ownK093893 Supera Veritas Interwoven Self-Expanding Nitinol Stent Transhepatic…Idev Technologies, Inc. · 2010 · Recalled
Showing 5 of 24 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 24 · See all- K031777Modeification to: Smart Control Nitinol Stent Transhepatic Biliary SystemCordis Corp. · 2003 · cites it directly10descendants
- K032457Modification to Smart Control Nitinol Stent Transhepatic Biliary SystemCordis Corp. · 2003 · cites it directly9descendants
- K060557Suresave TM Self-Expandable Nitinol Stent and Precision TM Delivery Catheter-SS06120060Idev Technologies, Inc. · 2006 · 2 generations on6descendants
- K071646Supera Interwoven Self-Expanding Biliary Nitinol Stent Delivery Catheter, Model #…Idev Technologies, Inc. · 2008 · 3 generations on5descendants
- K093893Supera Veritas Interwoven Self-Expanding Nitinol Stent Transhepatic Biliary SystemIdev Technologies, Inc. · 2010 · 3 generations on4descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K010445 | Precise Nitinol Stent Transhepatic Billary System | Cordis Corp. | 2001 | — |
| −1 | K012993 | Modification to Precise Nitinol Stent Transhepatic Biliary System | Cordis Corp. | 2001 | 1 |
| 0 (this device) | K021898 | Smart Control Nitinol Stent Transhepatic Biliary System | Cordis Corp. | 2002 | — |
| +1 | K031777 | Modeification to: Smart Control Nitinol Stent Transhepatic Biliary System | Cordis Corp. | 2003 | 3 |
| +1 | K032457 | Modification to Smart Control Nitinol Stent Transhepatic Biliary System | Cordis Corp. | 2003 | — |
| +2 | K060557 | Suresave TM Self-Expandable Nitinol Stent and Precision TM Delivery… | Idev Technologies, Inc. | 2006 | — |
| +3 | K071646 | Supera Interwoven Self-Expanding Biliary Nitinol Stent Delivery Catheter… | Idev Technologies, Inc. | 2008 | — |
| +3 | K093893 | Supera Veritas Interwoven Self-Expanding Nitinol Stent Transhepatic Biliary… | Idev Technologies, Inc. | 2010 | 1 |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 7 | 0 |
| 2004 | 2 | 0 |
| 2005 | 1 | 0 |
| 2006 | 2 | 0 |
| 2008 | 4 | 0 |
| 2010 | 2 | 0 |
| 2011 | 1 | 0 |
| 2012 | 2 | 0 |
| 2013 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FGE device
- #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K012993 | Modification to Precise Nitinol Stent Transhepatic Biliary System | 2001 |
| * | K001843 | S.M.a.R.T. Nitinol Stent Transhepatic Biliary System | 2000 |
| * | K971010 | Peripheral Transluminal Angioplasty CathetersSummary page 1…(Improved Radiopacity) (5 1O(k) # KO01843 - July 18,2000 - Cordis Corporation. Cordis SAVVYTM PTA Balloon Catheter (5 1O(k) # K97 1010 - June 18, 1997) - Cordis Corporation. Bridge SE Self Expanding Stent Delivery System… | 1997 |
| * | K011080 | Bridge SE Self-Expanding Stent Delivery System | 2001 |
What descends from it? (24)
See all 248 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K031777 | Modeification to: Smart Control Nitinol Stent Transhepatic Biliary System | 2003 | 10 |
| K032457 | Modification to Smart Control Nitinol Stent Transhepatic Biliary System | 2003 | 9 |
| K024303 | Edwards Lifesciences Lifestent NT18 Self-Expanding Biliary Stent and Delivery System | 2003 | 4 |
| K033393 | Absolute .035 Self-Expanding Biliary Stent System | 2003 | 3 |
| K023217 | Modification to Smart Control Nitinol Stent Transhepatic Biliary System | 2002 | 2 |
| K032137 | Precise RX Nitinol Stent Transhepatic Biliary System | 2003 | 0 |
| K031197 | Modification to Smart Control Nitinol Stent Transhepatic Biliary System | 2003 | 0 |
| K030409 | Smart Nitinol Stent Endoscopic Biliary System | 2003 | 0 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Feb 3, 2003 | Not classified | Z-0707-03 | Other | The SMART Control Stent Delivery System may not fully deploy or be difficult to deploy under certain circumstances. |
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 1 year and passes through 1 company; a new generation was cleared every 10 months on median.
- 1 of the 5 ancestors has a recall of any class.
- Of its descendants, K031777 (Cordis Corp., 2003) has gone furthest, with 10 descendants of its own.
- 2 other devices also cite its predicate K012993.
How does its category compare?
All FGE devicesFGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · FGE
7in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FGE
257in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FGE
1in 2024
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · FGE
1,923in 2025
MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 4 | 316 | 54 | 1,006 |
| 2008 | 11 | 214 | 93 | 1,465 |
| 2009 | 7 | 160 | 18 | 1,655 |
| 2010 | 9 | 81 | 32 | 1,434 |
| 2011 | 9 | 114 | 2 | 1,321 |
| 2012 | 8 | 96 | 4 | 1,183 |
| 2013 | 5 | 161 | 3 | 1,060 |
| 2014 | 8 | 156 | 0 | 1,270 |
| 2015 | 8 | 79 | 0 | 1,543 |
| 2016 | 4 | 49 | 0 | 1,453 |
| 2017 | 9 | 59 | 1 | 1,515 |
| 2018 | 7 | 215 | 43 | 1,681 |
| 2019 | 2 | — | 13 | 1,896 |
| 2020 | 4 | 121 | 1 | 2,182 |
| 2021 | 1 | — | 27 | 2,297 |
| 2022 | 6 | 101 | 21 | 1,749 |
| 2023 | 6 | 199 | 19 | 1,615 |
| 2024 | 6 | 188 | 1 | 1,948 |
| 2025 | 7 | 257 | 0 | 1,923 |
| 2026 | 8 | 153 | 11 | — |
What is it indicated for?
The Cordis SMART Control Nitinol Stent Transhepatic Biliary System is indicated for use in the palliation of malignant neoplasms in the biliary tree.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K021898 · printed Nov 6, 2026
Cite this page
510(k) Report. “K021898: Smart Control Nitinol Stent Transhepatic Biliary System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K021898
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026